Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: Intensive care and infection
Disease area: Airway diseases, Paediatric lung diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
V. Goyal (Brisbane, Australia), K. Grimwood (Gold Coast, Australia), R. Ware (Gold Coast, Australia), C. Brynes (Auckland, New Zealand), P. Morris (Darwin, Australia), I. Masters (Brisbane, Australia), G. Mccallum (Darwin, Australia), M. Binks (Darwin, Australia), H. Smith-Vaughan (Darwin, Australia), K. O’Grady (Brisbane, Australia), A. Champion (Brisbane, Australia), H. Buntain (Brisbane, Australia), A. Schultz (Perth, Australia), M. Chatfield (Brisbane, Australia), P. Torzillo (Sydney, Australia), A. Chang (Brisbane, Australia). Oral antibiotics vs placebo for exacerbations of paediatric bronchiectasis. 5101

Member's Comments

No comment yet.

Related content which might interest you: Amoxicillin-clavulanate versus azithromycin for respiratory exacerbations in children with bronchiectasis: the  BEST-2 trial Source: International Congress 2018 – Bronchiectasis: new insights in diagnosis and treatment Year: 2018 Comparison of oral prednisolone and nebulized budesonide in the treatment of acute exacerbations of COPD Source: Eur Respir J 2001; 18: Suppl. 33, 214s Year: 2001 Antibiotic treatment strategies in adults with bronchiectasis Source: Eur Respir Mon 2011; 52: 211-222 Year: 2011 Efficacy and safety of intravenous montelukast in patients with acute exacerbations of bronchial asthma Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma Year: 2008 Aerosolized budesonide therapy in acute moderate exacerbations of Indian asthmatics Source: Eur Respir J 2004; 24: Suppl. 48, 343s Year: 2004 A comparison of intravenous versus oral administration of corticosteroids in the treatment of patients admitted to the hospital with an exacerbation of COPD Source: Eur Respir J 2004; 24: Suppl. 48, 64s Year: 2004 Efficacy of a combination therapy with single inhaler budesonide/formoterol in the treatment of acute exacerbations of COPD (AECOPD) Source: Eur Respir J 2004; 24: Suppl. 48, 252s Year: 2004 Reduced risk for asthma exacerbations in pediatric patients receiving salmeterol plus inhaled corticosteroids (ICS) vs. ICS alone Source: Eur Respir J 2004; 24: Suppl. 48, 308s Year: 2004 Nebulized saline treatment in patients with concomitant asthma and bronchiectasis Source: Virtual Congress 2021 – Bronchiectasis and pleural infection Year: 2021 Long-term treatment with low-dose azithromycin reduces cough, sputum production and exacerbations in patients with idiopathic diffuse bronchiectasis Source: Eur Respir J 2004; 24: Suppl. 48, 707s Year: 2004 Exacerbations and inhaled corticosteroids in bronchiectasis patients Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis Year: 2019 Oral corticosteroids in the treatment of exacerbation of severe asthma Source: Virtual Congress 2020 – Exhaled biomarkers of asthma and the asthma burden Year: 2020 Efficacy of administration of 0.02% solution of decamethoxine via nebulizer in patients with infectious exacerbations of COPD Source: Annual Congress 2013 –COPD treatment Year: 2013 Penetration of moxifloxacin in bronchial secretions in hospitalized patients with acute exacerbation of COPD Source: Annual Congress 2013 –Antibiotics, resistance and vaccines Year: 2013 Clinical efficacy of nebulised budesonide in acute exacerbation of COPD Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010 The use of intravenous aminophylline in treatment of exacerbations of COPD Source: Annual Congress 2004 - Acute exacerbations and drug therapy in COPD Year: 2004 Erdosteine oral treatment of hospitalised COPD exacerbation prolongs time to first re-exacerbation Source: International Congress 2014 – Clinical trials of drugs and biomarkers for respiratory diseases Year: 2014 Efficacy of azithromycin vs. ciprofloxacin in the treatment of patients with acute bacterial exacerbations of chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 544s Year: 2002 Oral and inhalation usage of acetylcysteine in patients with COPD Source: International Congress 2019 – Advances in COPD pharmacology Year: 2019 Comparison of the effectiveness of parenteral and nebuliser steroid in COPD exacerbations Source: Eur Respir J 2002; 20: Suppl. 38, 243s Year: 2002